Big Pharma Corporate Finance -> Corporate Development

Hi! A little background -  currently working as an analyst for top 10 Big Pharma company [including internships been here for 3 years]. Not in FP&A but have had FP&A experience at this company (for a summer) working on an M&A deal. Lacking a lot of the deal exposure and experience desirable for a corp dev position.

1. Should I transition into FP&A and try and network to break into corp dev at my company?

2. Would getting an MBA help?

I am open to leaving my industry as well but feel as though I should leverage the experience I have in Pharma as a recent graduate. Any advice would be greatly appreciated.

5 Comments
 
I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Are you able to transition to M&A function at your current firm?

With little to no M&A experience, it will be incredibly difficult to make that transition. 

Have you considered transition to IB after MBA?

Authored by: Certified Corporate Development Professional - Director
 

I figured that transitioning into Biotech/Pharma IB after MBA would be the most apparent route to break into CorpDev for me.

Was just curious as to whether there was a more efficient track. Appreciate your response, would gladly accept any additional advice you have for me.

 

In the meantime, you can see if you can transition to a more finance-oriented role in your company (FPA if M&A is not as feasible at this stage). I would recommend researching more about IB in terms of networking and interviewing from WSO guides and Mergers & Inquisitions. 

Authored by: Certified Corporate Development Professional - Director
 

Consectetur quae aut reiciendis. Sed suscipit et dolore voluptatem ratione amet mollitia sit.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (78) $151
  • Intern/Summer Analyst (72) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
dosk17's picture
dosk17
98.9
7
CompBanker's picture
CompBanker
98.9
8
DrApeman's picture
DrApeman
98.9
9
GameTheory's picture
GameTheory
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”